Form 8-K GLOBUS MEDICAL INC For: May 08

Go back to Form 8-K GLOBUS MEDICAL INC For: May 08

Globus Medical (GMED) PT Lowered to $78 at Oppenheimer

May 9, 2025 10:21 AM EDT

Oppenheimer analyst Steven Lichtman lowered the price target on Globus Medical (NYSE: GMED) to $78.00 (from $90.00) while maintaining a Perform rating.

The analyst commented, "Globus Medical's 1Q25 sales of $598.1 (-0.8% constant currency) missed our/Street's ~$630.1/$626M estimates. Musculoskeletal was softer on several factors including timing... More